Is Medtronic's Artificial Pancreas the Next Big Thing in Diabetes?
Todd Campbell, Motley Fool ($MDT)
Boston Scientific Corporation Plans Study on Subcutaneous Implantable Defibrillator
Adam Russel, Market Exclusive ($BSX)
Irish stroke medtech firm Neuravi snapped up by Johnson & Johnson
Gordon Hunt, Silicon Republic ($JNJ)
Medtronic’s Ishrak sees Chinese health reform as boon to med device business
Fink Densford, Mass Device ($MDT)
Justice Department crackdown on price fixing ensnares Baxter
Crain's Chicago Business ($BAX)